Method and system for screening compounds for muscular and/or neurological activity in animals

• US 20060018833A1
• Filed: 04/07/2005
• Published: 01/26/2006
• Est. Priority Date: 04/07/2004
• Status: Abandoned Application

• Current Assignee: Randall Murphy, Vincent Pieribone
• Original Assignee: Randall Murphy, Vincent Pieribone
• Inventors: Pieribone, Vincent, Murphy, Randall
• Application Number:
  US11/101,151
• Publication Number:
  US 20060018833A1
• Time in Patent Office: Days
• US Class Current: 424/9.200
• CPC Class Codes: A61K 49/0008 Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
• CPC Class Codes: G01N 33/5088 of vertebrates

Abstract

Screening methods and instrumentation for candidate pharmacological agents are applied to discover compounds with muscular and/or neurological activity. The method comprises the use of teleost fish, such as the medaka (Oryzias latipes), which may be stimulated with chemical agents or an electric field to produce, for example, seizure activity and/or convulsive activity. The convulsive behavior may be recorded optically and electrically. Antagonism of the convulsive behavior is produced by application of candidate pharmacological agents to the well containing the fish. The method may include stimulation and antagonism in a plurality of sample wells with a repetitive or simultaneous application of threshold electric fields. The methods and instrumentation can be applied to the study of other serious neurological diseases such as neuropathic pain. In addition the process of assaying the protection of animals to convulsant agents the assay measures pharmacological safety parameters including sedation and cognitive impairment.

Claims

1. A method of identifying an agent that modifies a muscular activity, a neurological activity, or both comprising:

contacting a teleost fish with a muscular stimulus, a neurological stimulus, or both, and a test agent;

detecting the muscular activity, the neurological activity, or both in the teleost fish;

wherein when the test agent produces a detectable change in the muscular activity, the neurological activity, or both in the teleost fish, identifying the test agent as an agent that modifies the muscular activity, the neurological activity, or both.

2. The method of claim 1, additionally comprising

contacting a second teleost fish with a muscular stimulus, a neurological stimulus, or both;

detecting a second muscular activity, neurological activity, or both in the second teleost fish;

wherein when the test agent produces a detectable change that is a difference between in the muscular activity, the neurological activity, or both in the teleost fish contacted with the test agent and the second teleost fish, identifying the test agent as an agent that modifies the muscular activity, the neurological activity, or both.

3. The method of claim 1 or 2, wherein the muscular stimulus, the neurological stimulus, or both, comprises an electrical stimulus, a chemical stimulus, or both.

4. The method of claim 3, wherein detecting the muscular activity, the neurological activity, or both comprises detecting a behavioral response in the teleost fish.

5. The method of claim 4, wherein the behavioral response is rapid and erratic tail movements, or post-ictal inactivity.

6. The method of claim 1 or 2, wherein the teleost fish is a Oryzias latipes, Astronotus ocellatus, Danio rerio, Anguilla anguilla, Chelon labrosus, Salmo truttafario, Oncorhynchus mykiss, Oreochromis mossambicus, Eigenmannia virescens, Cyprinus carpio, Stephanolepis cirrhifer, Carassius auratus, Gasterosteus aculeatus, Clarias batrachus, Pimephales promelas, or Apteronotus leptorhnchus.

7. The method of claim 1 or 2, wherein detecting comprising recording the muscular activity, the neurological activity, or both in real time.

14. The method of any one of claims 1, 2, 8, or 9 wherein the muscular stimulus, the neurological stimulus, or both, is a convulsant stimulus, the detected muscular activity, neurological activity, or both is a convulsant activity, and the test agent inhibits the convulsant activity.

15. The method of claims 1, 2, 8, or 9 wherein the muscular stimulus, the neurological stimulus, or both is a neuropathic pain stimulus, the detected muscular activity, neurological activity, or both is a pain aversive activity, and the test agent inhibits the pain aversive activity.

16. The method of claim claims 1, 2, 8, or 9 wherein the muscular stimulus, the neurological stimulus, or both is a cardiac rhythm stimulus, the detected muscular activity, neurological activity, or both is a cardiac rhythm, and the test agent modifies the cardiac rhythm.

8. A method of screening comprising:

providing a plurality of test wells, each test well comprising at least one teleost fish,

contacting the teleost fish in at least a first fraction of the test wells with a test agent,

administering a muscular stimulus, a neurological stimulus, or both to the plurality of test wells,

detecting a muscular activity, a neurological activity, or both in the teleost fish;

wherein when the test agent produces a detectable change in the muscular activity, the neurological activity, or both in the teleost fish in at least one test well, identifying the test agent as an agent that modifies the muscular activity, the neurological activity, or both.

9. The method of claim 8 additionally comprising

as a subset of the plurality of test wells, a second fraction of test well in which the fish in the second fraction of test wells are not contacted with a test agent,

wherein when the test agent produces a detectable change that is a difference between in the muscular activity, the neurological activity, or both in the teleost fish in the first fraction of test wells and the muscular activity, the neurological activity, or both in the teleost fish in the second fraction of test wells,

identifying the test agent as an agent that modifies the muscular activity, the neurological activity, or both.

10. The method of claim 8 or 9, wherein the detecting is performed in real time and the means for detecting the muscular activity, the neurological activity, or both is any one of the following:

a plurality of photodetectors situated substantially adjacent to a side of a test well, and a plurality of photoemitters situated substantially adjacent to a side of a well substantially opposing the plurality of photodetectors;

electrodes present within at least one test well capable of detecting electromagnetic impulses generated by the motion of the fish in the well;

a microphone or a piezoelectric sensor present within at least one test well, wherein the microphone or piezoelectric sensor is capable of detecting electromagnetic impulses generated by the motion of the fish in the well;

a video camera, a CCD-based imaging system, or CMOS-based imaging system capable of recording the motion of the fish in the well;

magnetic sensing coils located parallel to the axis of the test well;

magnetic sensing coils which are located perpendicular to the axis of the test well;

multiple magnetic sensing coils located both parallel and perpendicular to the axis of the test well;

wherein the signal in the coils is quantified as the difference between the signals in the parallel and perpendicular coils;

multiple magnetic sensing coils located both parallel and perpendicular to the axis of the test well;

wherein the signal in the coils is quantified as the first derivative of the difference between the signals in the parallel and perpendicular coils;

or

a superconducting quantum interference device (SQUID) magnetometer located proximally to the wells, or a combination of any of the foregoing.

11. The method of claim 8 or 9, wherein the means for detecting the muscular activity, the neurological activity, or both comprises a plurality of photodetectors in communication with a plurality of photoemitters.

12. The method of claim 8 or 9 wherein the muscular stimulus, the neurological stimulus, or both is an electric field, a chemical stimulus, or both.

13. The method of claim 8 or 9, wherein the means for detecting the muscular activity, the neurological activity or both comprises:

a plurality of photodetectors capable of detecting seizure activity in the fish, wherein the photodetectors are situated substantially adjacent to a side of each well; and

a plurality of photoemitters situated substantially adjacent to a side of each well substantially opposing the array of photodetectors array; and

a means for recording the seizure activity in real time.

17. A screening system for identifying agents that modify a muscular activity, a neurological activity, or both comprising:

a plurality of test wells each test well comprising at least one teleost fish and at least one test well comprising a test agent,

a means for applying a muscular stimulus, a neurological stimulus, or both, wherein the means is sufficient to induce the muscular activity, the neurological activity, or both to the fish in the test wells; and

a means for detecting the muscular activity, the neurological activity, or both in the teleost fish.

18. The screening system of claim 17, further comprising a means for comparing the muscular activity, the neurological activity, or both in the teleost fish in the presence of a test agent to a control muscular activity, neurological activity, or both in the teleost fish in the absence of the test agent.

19. The system of claim 17, wherein the means for applying the muscular stimulus, neurological stimulus, or both is a pair of inert conductive electrodes capable of applying an electric field to the test wells.

20. The system of claim 17, comprising

a plurality of tests wells in the form of a multiwell plate,

a means for applying a convulsive stimulus sufficient to induce convulsive activity in the fish in the test wells, a means for applying a neuropathic pain stimulus sufficient to induce pain adversive activity in the fish in the test wells, or a cardiac rhythm stimulus sufficient to modify cardiac rhythm in the fish in the test wells

wherein the stimulus is either an electric field or a convulsive chemical.

21. The system of claim 17 or claim 20, wherein the means for detecting muscular and/or neurological activity in the fish comprises:

a plurality of photodetectors capable of detecting a muscular activity, a neurological activity, or both in the fish, wherein the photodetectors are situated substantially adjacent to a side of each well; and

a plurality of photoemitters situated substantially adjacent to a side of each well substantially opposing the array of photodetectors array; and

a means for recording the muscular activity, the neurological activity, or both, in real time,

wherein the muscular activity or neurological activity is a seizure activity, a cardiac rhythm, or a pain adversive activity.

22. The screening system of claim 17, additionally comprising a means for comparing seizure activity in the fish in the presence of a test agent to seizure activity in the fish in the absence of the test agent.

23. The system of claim 20, wherein the convulsive chemical is pentylenetetrazol, bicuculline, DMCM, FG 7142, strychnine, bemegride, 4-aminopyridine, kainate, NMDA, or any combination of the foregoing.

24. The system of claim 17, wherein the muscular stimulus, the neurological stimulus, or both is an electric field applied between alternating pairs of electrodes in an assembly in a sequential manner, and the average electric field experienced by the fish is substantially constant and substantially independent of the position of the teleost fish in the well.

25. The system of claim 24, wherein the photoemitters emit light not detectable by the fish, wherein the photodetectors are sensitive to this emitted light.

26. The system of claim 21, wherein the photoemitters emit light in a region of the electromagnetic spectrum not detectable by the fish, and the photodetectors are sensitive to light having this wavelength.

27. The system of claim 21, wherein the plurality of photoemitters emit light in the infrared or near-infrared region of the electromagnetic spectrum that is not detectable by the fish, and the photodetectors are sensitive to light having this wavelength.

28. The screening system of claim 17 or 20, further comprising a means for automatically adding reagents and fish to the wells.

29. The screening system of claim 21, additionally comprising a means for comparing the seizure activity in the fish in the presence of a test agent to seizure activity in the fish in the absence of the test agent.

30. The screening system of claim 17, wherein the test agents are analgesics.

31. The screening system of claim 17, wherein the test agents are agents to treat neurological diseases.

32. The screening system of claim 17, wherein the test agents are agents that are active on alpha- or beta-adrenoceptor subtypes.

33. The screening system of claim 17, wherein the test agents are agents that are active on dopamine receptor subtypes.

34. The screening system of claim 17, wherein the test agents are agents which ameliorate abnormalities in the Q-T cardiac interval.